Prothrombin Complex Concentrates - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Prothrombin Complex Concentrates - Global Top Players Market Share and Ranking 2025

Prothrombin Complex Concentrates - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-13
Report Id: 2765165
Industry: Pharma & Healthcare
Report Page: 114
Chart: 118

PDF Download

Publication Date: 2025-11-13
Report Id: 2765165
Industry: Pharma & Healthcare
Report Page: 114
Chart: 118

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Prothrombin Complex Concentrates Definition
1.2 Global Prothrombin Complex Concentrates Market Size and Forecast
1.2.1 By Consumption Value, Global Prothrombin Complex Concentrates Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Prothrombin Complex Concentrates Market Size, 2020-2031
1.2.3 Global Prothrombin Complex Concentrates Average Selling Price (ASP), 2020-2031
1.3 China Prothrombin Complex Concentrates Market Size and Forecast
1.3.1 By Consumption Value, China Prothrombin Complex Concentrates Market Size, 2020-2031
1.3.2 By Sales Quantity, China Prothrombin Complex Concentrates Market Size, 2020-2031
1.3.3 China Prothrombin Complex Concentrates Average Selling Price (ASP), 2020-2031
1.4 Share of China Prothrombin Complex Concentrates Market with Respect to the Global Market
1.4.1 By Consumption Value, China Prothrombin Complex Concentrates Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Prothrombin Complex Concentrates Market Share in Global, 2020-2031
1.4.3 Prothrombin Complex Concentrates Market Size: China VS Global, 2020-2031
1.5 Prothrombin Complex Concentrates Market Dynamics
1.5.1 Prothrombin Complex Concentrates Market Drivers
1.5.2 Prothrombin Complex Concentrates Market Restraints
1.5.3 Prothrombin Complex Concentrates Industry Trends
1.5.4 Prothrombin Complex Concentrates Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Prothrombin Complex Concentrates, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Prothrombin Complex Concentrates, Global Market Share by Company, 2020-2025
2.3 Prothrombin Complex Concentrates Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Prothrombin Complex Concentrates Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Prothrombin Complex Concentrates Concentration Ratio
2.6 Global Prothrombin Complex Concentrates Mergers & Acquisitions, Expansion Plans
2.7 Global Prothrombin Complex Concentrates Manufacturers Product Type
2.8 Head Office and Prothrombin Complex Concentrates Production Site of Key Manufacturer
2.9 Prothrombin Complex Concentrates Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Prothrombin Complex Concentrates, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Prothrombin Complex Concentrates, China Market Share by Company, 2020-2025
3.3 China Prothrombin Complex Concentrates Prothrombin Complex Concentrates Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Prothrombin Complex Concentrates Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Prothrombin Complex Concentrates Capacity by Region
4.3 Global Prothrombin Complex Concentrates Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Prothrombin Complex Concentrates Production by Region, 2020-2031
4.5 Global Prothrombin Complex Concentrates Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Prothrombin Complex Concentrates Industry Chain
5.2 Prothrombin Complex Concentrates Upstream Analysis
5.2.1 Prothrombin Complex Concentrates Core Raw Materials
5.2.2 Main Manufacturers of Prothrombin Complex Concentrates Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Prothrombin Complex Concentrates Production Mode
5.6 Prothrombin Complex Concentrates Procurement Model
5.7 Prothrombin Complex Concentrates Industry Sales Model and Sales Channels
5.7.1 Prothrombin Complex Concentrates Sales Model
5.7.2 Prothrombin Complex Concentrates Typical Distributors

6 Sights by Type
6.1 Prothrombin Complex Concentrates Classification by Type
6.1.1 Beriplex
6.1.2 Profilnine
6.1.3 Octaplex
6.1.4 Prothromplex
6.1.5 Cofact
6.1.6 Other
6.2 by Type, Global Prothrombin Complex Concentrates Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Prothrombin Complex Concentrates Consumption Value, 2020-2031
6.4 by Type, Global Prothrombin Complex Concentrates Sales Quantity, 2020-2031
6.5 by Type, Global Prothrombin Complex Concentrates Average Selling Price (ASP), 2020-2031

7 Sights by Usage Type
7.1 Prothrombin Complex Concentrates Classification by Usage Type
7.1.1 Lyophilized Powder Form
7.1.2 Liquid Injection Form
7.2 by Usage Type, Global Prothrombin Complex Concentrates Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Usage Type, Global Prothrombin Complex Concentrates Consumption Value, 2020-2031
7.4 by Usage Type, Global Prothrombin Complex Concentrates Sales Quantity, 2020-2031
7.5 by Usage Type, Global Prothrombin Complex Concentrates Average Selling Price (ASP), 2020-2031

8 Sights by Manufacturing Process
8.1 Prothrombin Complex Concentrates Classification by Manufacturing Process
8.1.1 Plasma-Derived
8.1.2 Recombinant Bioengineered
8.2 by Manufacturing Process, Global Prothrombin Complex Concentrates Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Manufacturing Process, Global Prothrombin Complex Concentrates Consumption Value, 2020-2031
8.4 by Manufacturing Process, Global Prothrombin Complex Concentrates Sales Quantity, 2020-2031
8.5 by Manufacturing Process, Global Prothrombin Complex Concentrates Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Prothrombin Complex Concentrates Segment by Application
9.1.1 Compound Pharmacies
9.1.2 Hospital Pharmacies
9.1.3 Retail Pharmacies
9.2 by Application, Global Prothrombin Complex Concentrates Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Prothrombin Complex Concentrates Consumption Value, 2020-2031
9.4 by Application, Global Prothrombin Complex Concentrates Sales Quantity, 2020-2031
9.5 by Application, Global Prothrombin Complex Concentrates Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Prothrombin Complex Concentrates Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Prothrombin Complex Concentrates Consumption Value, 2020-2031
10.3 By Region, Global Prothrombin Complex Concentrates Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Prothrombin Complex Concentrates Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Prothrombin Complex Concentrates Market Size Market Share
10.5 Europe
10.5.1 Europe Prothrombin Complex Concentrates Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Prothrombin Complex Concentrates Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Prothrombin Complex Concentrates Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Prothrombin Complex Concentrates Market Size Market Share
10.7 South America
10.7.1 South America Prothrombin Complex Concentrates Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Prothrombin Complex Concentrates Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Prothrombin Complex Concentrates Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Prothrombin Complex Concentrates Consumption Value, 2020-2031
11.3 By Country, Global Prothrombin Complex Concentrates Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Prothrombin Complex Concentrates Market Size, 2020-2031
11.4.2 by Type, United States Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Prothrombin Complex Concentrates Market Size, 2020-2031
11.5.2 by Type, Europe Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Prothrombin Complex Concentrates Market Size, 2020-2031
11.6.2 by Type, China Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Prothrombin Complex Concentrates Market Size, 2020-2031
11.7.2 by Type, Japan Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Prothrombin Complex Concentrates Market Size, 2020-2031
11.8.2 by Type, South Korea Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Prothrombin Complex Concentrates Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Prothrombin Complex Concentrates Market Size, 2020-2031
11.10.2 by Type, India Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Prothrombin Complex Concentrates Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Prothrombin Complex Concentrates Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 CSL Behring
12.1.1 CSL Behring Company Information, Head Office, Market Area, and Industry Position
12.1.2 CSL Behring Prothrombin Complex Concentrates Models, Specifications, and Application
12.1.3 CSL Behring Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 CSL Behring Company Profile and Main Business
12.1.5 CSL Behring Recent Developments
12.2 Grifols
12.2.1 Grifols Company Information, Head Office, Market Area, and Industry Position
12.2.2 Grifols Prothrombin Complex Concentrates Models, Specifications, and Application
12.2.3 Grifols Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Grifols Company Profile and Main Business
12.2.5 Grifols Recent Developments
12.3 Octapharma
12.3.1 Octapharma Company Information, Head Office, Market Area, and Industry Position
12.3.2 Octapharma Prothrombin Complex Concentrates Models, Specifications, and Application
12.3.3 Octapharma Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Octapharma Company Profile and Main Business
12.3.5 Octapharma Recent Developments
12.4 Prothya Biosolutions
12.4.1 Prothya Biosolutions Company Information, Head Office, Market Area, and Industry Position
12.4.2 Prothya Biosolutions Prothrombin Complex Concentrates Models, Specifications, and Application
12.4.3 Prothya Biosolutions Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Prothya Biosolutions Company Profile and Main Business
12.4.5 Prothya Biosolutions Recent Developments
12.5 Takeda
12.5.1 Takeda Company Information, Head Office, Market Area, and Industry Position
12.5.2 Takeda Prothrombin Complex Concentrates Models, Specifications, and Application
12.5.3 Takeda Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Takeda Company Profile and Main Business
12.5.5 Takeda Recent Developments
12.6 RAAS
12.6.1 RAAS Company Information, Head Office, Market Area, and Industry Position
12.6.2 RAAS Prothrombin Complex Concentrates Models, Specifications, and Application
12.6.3 RAAS Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 RAAS Company Profile and Main Business
12.6.5 RAAS Recent Developments
12.7 Hualan Bio
12.7.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
12.7.2 Hualan Bio Prothrombin Complex Concentrates Models, Specifications, and Application
12.7.3 Hualan Bio Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Hualan Bio Company Profile and Main Business
12.7.5 Hualan Bio Recent Developments
12.8 BOHUI
12.8.1 BOHUI Company Information, Head Office, Market Area, and Industry Position
12.8.2 BOHUI Prothrombin Complex Concentrates Models, Specifications, and Application
12.8.3 BOHUI Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 BOHUI Company Profile and Main Business
12.8.5 BOHUI Recent Developments
12.9 NUOYI BIO
12.9.1 NUOYI BIO Company Information, Head Office, Market Area, and Industry Position
12.9.2 NUOYI BIO Prothrombin Complex Concentrates Models, Specifications, and Application
12.9.3 NUOYI BIO Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 NUOYI BIO Company Profile and Main Business
12.9.5 NUOYI BIO Recent Developments
12.10 SINOPHARM
12.10.1 SINOPHARM Company Information, Head Office, Market Area, and Industry Position
12.10.2 SINOPHARM Prothrombin Complex Concentrates Models, Specifications, and Application
12.10.3 SINOPHARM Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 SINOPHARM Company Profile and Main Business
12.10.5 SINOPHARM Recent Developments
12.11 Guangdong Weilun
12.11.1 Guangdong Weilun Company Information, Head Office, Market Area, and Industry Position
12.11.2 Guangdong Weilun Prothrombin Complex Concentrates Models, Specifications, and Application
12.11.3 Guangdong Weilun Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Guangdong Weilun Company Profile and Main Business
12.11.5 Guangdong Weilun Recent Developments
12.12 Weiguang Bio
12.12.1 Weiguang Bio Company Information, Head Office, Market Area, and Industry Position
12.12.2 Weiguang Bio Prothrombin Complex Concentrates Models, Specifications, and Application
12.12.3 Weiguang Bio Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.12.4 Weiguang Bio Company Profile and Main Business
12.12.5 Weiguang Bio Recent Developments
12.13 Kangbo Bio
12.13.1 Kangbo Bio Company Information, Head Office, Market Area, and Industry Position
12.13.2 Kangbo Bio Prothrombin Complex Concentrates Models, Specifications, and Application
12.13.3 Kangbo Bio Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.13.4 Kangbo Bio Company Profile and Main Business
12.13.5 Kangbo Bio Recent Developments
12.14 Huarun Boya
12.14.1 Huarun Boya Company Information, Head Office, Market Area, and Industry Position
12.14.2 Huarun Boya Prothrombin Complex Concentrates Models, Specifications, and Application
12.14.3 Huarun Boya Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.14.4 Huarun Boya Company Profile and Main Business
12.14.5 Huarun Boya Recent Developments
12.15 Taibang Biologic
12.15.1 Taibang Biologic Company Information, Head Office, Market Area, and Industry Position
12.15.2 Taibang Biologic Prothrombin Complex Concentrates Models, Specifications, and Application
12.15.3 Taibang Biologic Prothrombin Complex Concentrates Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.15.4 Taibang Biologic Company Profile and Main Business
12.15.5 Taibang Biologic Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Prothrombin Complex Concentrates should grow from US$ 1408 million in 2024 to US$ 2724 million by 2031, with a CAGR of 9.7% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Prothrombin Complex Concentrates

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Prothrombin Complex Concentrates (PCC) are plasma-derived, multi-factor coagulation products that undergo viral inactivation and high-purity fractionation processes. They primarily contain four vitamin K-dependent clotting factors—II, VII, IX, and X—and may also include natural anticoagulants such as proteins C and S. PCCs are used to treat or prevent bleeding caused by deficiencies of these factors, particularly in cases of warfarin overdose, severe liver dysfunction, traumatic hemorrhage, or congenital coagulation disorders. Compared with traditional fresh frozen plasma, PCCs offer rapid onset, lower infusion volumes, and reduced infection risk, making them widely used in emergency anticoagulant reversal, surgical hemostasis, and critical care. With the expansion of anticoagulant therapy populations and increased surgical procedures, PCCs have become one of the fastest-growing therapeutic segments in the plasma products market.In 2024, global Prothrombin Complex Concentrate production reached approximately 4.73 m units, with an average global market price of around US$ 280 perunit.The average gross profit margin of this product is 80%.

The rapid development of the PCC market is primarily driven by the global rise in anticoagulant drug use and the strengthening of blood safety standards. The growing elderly population and the increasing prevalence of cardiovascular diseases have led to a surge in patients on long-term oral anticoagulants, generating strong demand for effective reversal agents. Meanwhile, PCC’s ability to rapidly restore coagulation in high-risk surgeries—such as trauma, neurosurgical, and cardiothoracic procedures—has significantly enhanced its clinical value. Stricter regulatory standards for plasma product purification and viral inactivation have accelerated the shift from three-factor to four-factor PCCs. In addition, the introduction of new-generation lyophilized and ready-to-use formulations has improved convenience and emergency accessibility, further expanding clinical adoption.

Despite the strong market outlook, the PCC industry faces multiple challenges. The supply of human plasma, the key raw material, is constrained by collection policies and demand fluctuations; shortages can arise due to pandemics, regulatory restrictions, or regional limitations. Moreover, the potential risk of thromboembolic complications associated with high-dose PCC administration limits its broad clinical use. The manufacturing process involves complex purification and viral inactivation technologies that require advanced equipment, regulatory compliance, and strict quality assurance, contributing to high industry concentration. In addition, in some developing countries, the preference for lower-cost substitutes such as fresh frozen plasma or recombinant factor therapies continues to hinder PCC market penetration.

The downstream demand for PCCs is expanding beyond traditional warfarin reversal to broader hemostatic indications. With the widespread adoption of direct oral anticoagulants (DOACs), PCCs are increasingly used for non-specific reversal of bleeding associated with these agents. Moreover, their adjunctive role in managing liver failure, obstetric hemorrhage, and trauma-induced coagulopathy has gained strong clinical validation. In developed countries, clinical guidelines now recommend PCC as a first-line treatment for anticoagulation reversal, promoting routine use in emergency and surgical care. In emerging markets, improvements in local plasma fractionation capacity and national blood product self-sufficiency programs are rapidly enhancing PCC accessibility and utilization.

The production of Prothrombin Complex Concentrates relies heavily on high-quality human plasma as its core raw material. The scale, stability, and compliance of plasma collection directly determine manufacturing capacity and product safety. Currently, plasma collection is concentrated in North America and Europe, where mature donor networks and traceability systems exist. In recent years, Asian countries such as China, India, and South Korea have emerged as new sources of plasma supply amid gradual policy liberalization. Besides plasma, PCC production depends on high-performance chromatography media, viral inactivation reagents, lyophilization equipment, and rigorous quality control systems. Innovations in upstream processes—such as multi-step chromatography and nanofiltration—have improved yield and purity, yet cross-border plasma transport remains constrained by ethical and regulatory limitations, continuing to pose a major bottleneck to global supply chain efficiency.

This report studies and analyses global Prothrombin Complex Concentrates status and future trends, helps the client to determine the Prothrombin Complex Concentrates market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Prothrombin Complex Concentrates, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Prothrombin Complex Concentrates market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Prothrombin Complex Concentrates sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Prothrombin Complex Concentrates sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Prothrombin Complex Concentrates key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Prothrombin Complex Concentrates key producing regions, capacity, production, and year over year growth
(6) Prothrombin Complex Concentrates industry chains, upstream, midstream and downstream
Market segment by players, this report covers
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
RAAS
Hualan Bio
BOHUI
NUOYI BIO
SINOPHARM
Guangdong Weilun
Weiguang Bio
Kangbo Bio
Huarun Boya
Taibang Biologic

Market segment by Type, covers
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other

Market segment by Usage Type, covers
Lyophilized Powder Form
Liquid Injection Form

Market segment by Manufacturing Process, covers
Plasma-Derived
Recombinant Bioengineered

Market segment by Application, can be divided into
Compound Pharmacies
Hospital Pharmacies
Retail Pharmacies

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Prothrombin Complex Concentrates product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Prothrombin Complex Concentrates market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Prothrombin Complex Concentrates market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Prothrombin Complex Concentrates, percent & CAGR, 2020-2031
Chapter 5: Prothrombin Complex Concentrates industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.